Palatin Technologies
PTN
#10075
Rank
S$35.48 M
Marketcap
S$20.84
Share price
5.47%
Change (1 day)
1,485.25%
Change (1 year)

Market capitalization of Palatin Technologies (PTN)

Market cap: S$35.48 Million

As of December 2025 Palatin Technologies has a market cap of S$35.48 Million. This makes Palatin Technologies the world's 10075th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Palatin Technologies from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025S$35.48 M0.27%
2024S$35.38 M-50.99%
2023S$72.2 M103.21%
2022S$35.53 M-77.79%
2021S$0.16 B-22.2%
2020S$0.20 B-14.9%
2019S$0.24 B22.98%
2018S$0.19 B-10.11%
2017S$0.21 B124.15%
2016S$97.53 M52.65%
2015S$63.89 M59.47%
2014S$40.06 M9.94%
2013S$36.44 M27.56%
2012S$28.57 M57.3%
2011S$18.16 M-11.88%
2010S$20.61 M-58.7%
2009S$49.91 M347.95%
2008S$11.14 M-54.56%
2007S$24.52 M-88.99%
2006S$0.22 B-30.56%
2005S$0.32 B36.77%
2004S$0.23 B21.54%
2003S$0.19 B98.04%
2002S$97.39 M-22.23%
2001S$0.12 B97.02%
2000S$63.56 M107.92%
1999S$30.56 M-12.4%
1998S$34.89 M15.06%
1997S$30.32 M758.52%
1996S$3.53 M

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Palatin Technologies was reported to be:

S$34.1 Million
by Nasdaq info icon info icon
S$33.64 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MediciNova
MNOV
S$84.09 M 136.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
S$13.03 M-63.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$18.90 B 53,162.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$2.34 B 6,504.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$5.02 B 14,072.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.83 B 10,695.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$637.42 B 1,796,160.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$1.79 B 4,947.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$367.89 B 1,036,625.79%๐Ÿ‡ฌ๐Ÿ‡ง UK